Cellectis S.A.
CLLS
$2.97
-$0.02-0.67%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 155.00K | 178.00K | 139.00K | 16.02M | 175.00K |
| Total Other Revenue | 1.49M | 1.82M | 3.42M | 1.30M | 1.70M |
| Total Revenue | 1.64M | 2.00M | 3.56M | 17.32M | 1.88M |
| Cost of Revenue | 181.00K | 55.00K | 334.00K | 690.00K | 367.00K |
| Gross Profit | 1.46M | 1.95M | 3.23M | 16.63M | 1.51M |
| SG&A Expenses | 3.23M | 3.95M | 4.96M | 1.70M | 4.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 12.00K | -490.00K | 111.00K | -839.00K | 125.00K |
| Total Operating Expenses | 22.31M | 25.66M | 26.49M | 22.98M | 29.23M |
| Operating Income | -20.67M | -23.66M | -22.93M | -5.66M | -27.35M |
| Income Before Tax | -17.38M | -7.68M | -27.83M | -25.62M | -25.55M |
| Income Tax Expenses | 106.00K | 258.00K | -- | 87.00K | -- |
| Earnings from Continuing Operations | -17.48M | -7.94M | -27.83M | -25.70M | -25.55M |
| Earnings from Discontinued Operations | -- | -5.65M | -4.69M | -2.86M | -5.72M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 2.94M | 2.45M | 1.74M | 2.80M |
| Net Income | -17.48M | -10.65M | -30.07M | -26.82M | -28.47M |
| EBIT | -20.67M | -23.66M | -22.93M | -5.66M | -27.35M |
| EBITDA | -18.18M | -21.20M | -20.49M | -3.09M | -24.79M |
| EPS Basic | -0.31 | -0.19 | -0.58 | -0.59 | -0.63 |
| Normalized Basic EPS | -0.25 | -0.03 | -0.28 | -0.31 | -0.26 |
| EPS Diluted | -0.31 | -0.19 | -0.58 | -0.59 | -0.63 |
| Normalized Diluted EPS | -0.25 | -0.03 | -0.28 | -0.31 | -0.26 |
| Average Basic Shares Outstanding | 55.58M | 56.04M | 51.45M | 45.65M | 45.54M |
| Average Diluted Shares Outstanding | 55.58M | 56.04M | 51.45M | 45.65M | 45.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
